Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Uni-medica is a China-based in vitro diagnostics company focused on molecular diagnostic products, instruments, and laboratory solutions. The company develops and commercializes assays and related workflows for infectious diseases, women\u2019s health, genetic diseases, and selected oncology screening applications. Its technology base includes multiplex PCR, next-generation sequencing, flow cytometry, fluorescence-based platforms, and immunochromatography. Uni-medica appears to operate as a revenue-generating commercial diagnostics manufacturer rather than a therapeutic drug developer, with products sold internationally and quality systems including ISO 9001 and ISO 13485. The company also collaborates with academic and clinical institutions in China and abroad on molecular diagnostics research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Uni-medica.